Abnormal cervical cytology and health care use: A population-based register study

2015 ◽  
Vol 139 (1) ◽  
pp. 63-69
Author(s):  
Maria Eiholm Frederiksen ◽  
Miguel Vázquez-Prada Baillet ◽  
Pierre-Antoine Dugué ◽  
Pernille Tine Jensen ◽  
Carsten Rygaard ◽  
...  
2021 ◽  
Vol 161 (2) ◽  
pp. 565-572
Author(s):  
Malene Skorstengaard ◽  
Maria Eiholm Frederiksen ◽  
Miguel Vázquez-Prada Baillet ◽  
Anna-Belle Beau ◽  
Pernille Tine Jensen ◽  
...  

2021 ◽  
Author(s):  
Aditi Desai ◽  
Rinku Sutradhar ◽  
Cindy Lau ◽  
Douglas S. Lee ◽  
Paul C. Nathan ◽  
...  

2018 ◽  
Vol 27 (5) ◽  
pp. 1935-1944
Author(s):  
Melissa S. Y. Thong ◽  
Floortje Mols ◽  
Adrian A. Kaptein ◽  
Dorry Boll ◽  
Caroline Vos ◽  
...  

CJEM ◽  
2015 ◽  
Vol 17 (5) ◽  
pp. 497-506
Author(s):  
Amanda S. Newton ◽  
Conrad I. Tsang ◽  
Rhonda J. Rosychuk

AbstractObjectiveTo examine sociodemographic variations among children <18 years in (1) rates of self-harm visits to emergency departments (EDs) and (2) physician follow-up after the self-harm visit in Alberta.MethodsA retrospective, population-based cohort (2002–2011) of ED visits for self-harm by individuals <18 years was conducted using administrative databases from Alberta, Canada. Individuals were grouped by First Nations status or type of health care premium subsidy (family receipt of government subsidy, human services program subsidy, no subsidy received). Visits from 104 EDs were summarized by crude and directly standardized visit rates (DSVRs) per 100,000 individuals. Kaplan-Meier estimates for median estimated time to physician follow-up were calculated with 95% confidence intervals (CIs).ResultsDuring the study period, visit rates decreased with the exception of children from families receiving government-sponsored program subsidy (DSVRs 163/100,000 to 250/100,000;p=0.032). First Nations children had disproportionately fewer follow-up visits compared to other children. The median time to follow-up for First Nations children was 39 days (95% CI: 32, 48) compared to 16 days for children from families receiving no subsidy (95% CI: 14, 19), who had the shortest follow-up time after an ED visit.ConclusionsSociodemographic differences were evident in ED visit rates as well as the number of and time to physician follow-up visit. The disparities experienced by First Nations children in the follow-up period highlight an opportunity for culturally-grounded risk and needs assessment in the ED to determine and facilitate timely and appropriate follow-up care.


CMAJ Open ◽  
2014 ◽  
Vol 2 (1) ◽  
pp. E27-E34 ◽  
Author(s):  
R. G. Weaver ◽  
B. J. Manns ◽  
M. Tonelli ◽  
C. Sanmartin ◽  
D. J. T. Campbell ◽  
...  

2013 ◽  
Vol 7 (02) ◽  
pp. 130-136 ◽  
Author(s):  
Rana Al-Awadhi ◽  
Wassim Chehadeh ◽  
Waleed Al-Jassar ◽  
Jehad Al-Harmi ◽  
Eyad Al-Saleh ◽  
...  

Introduction: Human papillomaviruses (HPV) are the most commonly known sexually transmitted agents. Almost all cases of cervical cancer are caused by persistent infection. This study was conducted to ascertain whether there is a difference in HPV load in cervical samples with normal and abnormal cervical cytology reports in Kuwait. Methodology: HPV-positive abnormal ThinPrep samples (n = 206) and normal ThinPrep samples (n = 120) were taken from women attending gynecology clinics. Real-time PCR was used to measure the viral load for all HPV genotypes. Results: The median normalized viral load in samples with normal and abnormal cytology reports was 0.86 × 10-7 and 4.66 × 10-7, respectively (p = 0.001). Median normalized viral load of high-risk (HR), intermediate-risk (IR) and low-risk (LR) HPV was 4.04 × 10-7, 0.71 × 10-7 and 2.38 × 10-7, respectively, (p = 0.002). Conclusions: The findings suggest that, in the absence of a proper screening programme in Kuwait, quantification of HPV viral load could be considered as a surrogate virology test to identify women with abnormal cytology. Further population-based prospective studies are needed to include more women with high-grade and invasive carcinoma reports.


2019 ◽  
Vol 98 (6) ◽  
pp. 777-786 ◽  
Author(s):  
Tagrid Jar‐Allah ◽  
Cecilia Kärrberg ◽  
Johanna Wiik ◽  
Verena Sengpiel ◽  
Björn Strander ◽  
...  

2019 ◽  
Vol 8 (8) ◽  
pp. 1191 ◽  
Author(s):  
Seona Park ◽  
Jihye Kim ◽  
Jaeyoung Chun ◽  
Kyungdo Han ◽  
Hosim Soh ◽  
...  

Background and Aims: It is not known whether inflammatory bowel disease (IBD) enhances the risk of Parkinson’s disease (PD) or whether PD diagnosis is the result of increased health care use. We determined the risk of developing PD among patients with IBD in terms of health care and medication use. Methods: A nationwide population-based study was conducted using claims data from the Korean National Health care Insurance service. From 2010 to 2013, patients with Crohn’s disease (CD) and ulcerative colitis (UC) were identified through both International Classification of Disease, Tenth Revision (ICD-10) and national rare intractable disease (RID) registration program codes. We compared 38,861 IBD patients with age and sex-matched non-IBD individuals at a ratio of 1:3. Patients with newly diagnosed PD were identified through both ICD-10 and RID codes. Results: The incidence of PD among patients with IBD was 49 per 100,000 person-years. The risk of developing PD in patients with IBD was significantly higher than controls even after adjustment for health care use (adjusted hazard ratio (aHR), 1.87; P < 0.001). Compared to controls, the risk of PD was significantly higher in patients with CD (aHR, 2.23; P = 0.023) and UC (aHR, 1.85; P < 0.001). Corticosteroid use showed a preventive effect on developing PD in patients with CD (aHR 0.08; P < 0.001), but not UC (aHR, 0.75; P = 0.213). Among 2110 patients receiving anti-tumor necrosis factor (anti-TNF), none of the treated patients experienced PD during 9950 person-years. Conclusion: Patients with IBD are at an increased risk of PD, regardless of health care use. Corticosteroid and anti-TNF use may prevent PD in patients with IBD.


Sign in / Sign up

Export Citation Format

Share Document